Pemivibart Side Effects
Applies to pemivibart: intravenous solution.
Important warnings
This medicine can cause some serious health issues
The US Food and Drug Administration (FDA) has authorized emergency use of pemivibart for prevention of COVID-19 in adults and children at least 12 years of age who weigh at least 88 lbs (40 kg).
Some side effects may occur during or after the injection.
Tell your medical caregiver right away if you feel light-headed, chest tightness, trouble breathing, or swelling in your face.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Some side effects may occur during and after receiving the pemivibart injection. Tell your medical caregivers if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, swelling in your face, flushing (sudden warmth, redness, or tingly feeling), ringing in your ears, or have fast heartbeats.
Your treatment may be permanently discontinued if you have certain side effects.
Common side effects may include:
-
pain, bruising, swelling, warmth, redness, a possible infection, or bleeding where the IV needle is placed;
-
feeling unwell during the injection;
-
flu-like symptoms, cold symptoms, viral infections;
-
headache, tiredness; or
-
nausea.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
More about pemivibart
- Check interactions
- Compare alternatives
- Dosage information
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Pemivibart side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
